Retention rate of secukinumab in psoriatic arthritis: Real-world data results from a Spanish multicenter cohort-Reference-Cited by-同舟云学术

Retention rate of secukinumab in psoriatic arthritis: Real-world data results from a Spanish multicenter cohort

Published:2022-09-09 Issue:36 Volume:101 Page:e30444
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Valero-Expósito Marta,Martín-López María,Guillén-Astete Carlos,Joven Beatriz,Merino-Argumanez Carolina,Emperiale Valentina,Campos Jose,Pérez Ana,Bachiller-Corral Javier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference24 articles.

1. Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study.;Romero Pérez;PLoS One,2020

2. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): aims and methodology.;Seoane-Mato;Reumatol Clin,2019

3. Biologic treatments of psoriasis: an update for the clinician.;Brownstone;Biologics,2021

4. Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis.;Furue;Cytokine,2018

5. Recommendations of the Spanish society of rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.;Torre Alonso;Reumatol Clin,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort;2024-03-25

2. Long-term retention rates of anti-tumour necrosis factor and anti-interleukin-17 antibodies for patients with psoriatic arthritis;Modern Rheumatology;2023-12-07

3. Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study;Advances in Therapy;2023-10-07